Prostate cancer decisions — 2024

The appeal for hypertension is dismissed. Entitlement to service connection for prostate cancer is granted without reliance on the PACT Act.

The Board has remanded the claims for prostate cancer, erectile dysfunction, skin cancer of the head, and PTSD due to potential issues with verifying exposure to herbicide agents and a stressor. Additional medical opinions are needed regarding the PTSD claim.

The Board has denied service connection for hypertension, gastroesophageal reflux disease (GERD), and prostate cancer as the evidence does not support a nexus to military service or herbicide exposure.

The Board has granted service connection for prostate cancer due to exposure to herbicide agents during service in Guam, finding the evidence in equipoise as to whether the Veteran was exposed to these agents.

The Veteran's hepatic steatosis is denied as there is no evidence of a disease or injury during service, and the VA examiner found it less likely than not related to exposure to contaminated water at Camp Lejeune.,The Veteran's prostate cancer is remanded for a medical opinion regarding its relationship to his service, specifically exposure to contaminated water at Camp Lejeune.

The Board has remanded the claims for diabetes mellitus, prostate cancer, skin condition, and bilateral foot condition due to inadequate rationale in previous opinions and unclear nature of in-service exposures.

The Veteran withdrew his appeals for the lumbar spine disability and prostate cancer claims, resulting in their dismissal.

The Board has denied service connection for pancreatitis and prostate cancer, both for accrued benefits purposes. The Veteran's pancreatitis was not shown as chronic in service or within the applicable presumptive period; continuity of symptomatology is not established; and the disability is not otherwise etiologically related to an in-service injury or disease. Service connection on a direct basis may still be considered.,The Board has also denied service connection for prostate cancer, both for accrued benefits purposes. The Veteran's prostate cancer was not shown as chronic in service or within the applicable presumptive period; continuity of symptomatology is not established; and the disability is not otherwise etiologically related to an in-service injury or disease. Service connection on a direct basis may still be considered.,The Board has remanded for further development regarding a compensable rating for bladder cancer residuals, both for accrued benefits purposes. The Veteran reported frequent night wakings for urination, and the appellant testified to such at the hearing.

The Veteran's diabetes mellitus type II with erectile dysfunction is currently rated at 40 percent prior to January 14, 2015 and 60 percent thereafter. The appeal for increased ratings remains pending.,Secondary service connection claims for hypertension and an eye disability are remanded.

The Board has granted service connection for prostate cancer, finding that the Veteran's exposure to diesel fumes during his military service is etiologically related to his current condition.

The Veteran's appeal for an increased rating for prostate cancer and a compensable rating for erectile dysfunction was denied. The prostate cancer is rated at 40 percent, effective January 1, 2019. The erectile dysfunction claim remains in place as the Veteran does not have a deformity that would warrant a higher rating.

The Veteran's claims for service connection for type II diabetes mellitus, prostate cancer, malignant melanoma, neuropathy of the left arm, right leg, and left leg, as well as hypertension are all denied.

The Veteran's prostate cancer residuals, including urinary frequency and incontinence issues, are now rated at 40 percent effective May 8, 2023.

The Board has dismissed the appeals for service connection of Parkinson's disease and prostate cancer due to the death of the appellant during the pendency of the appeal.

The Board has remanded the case for further development regarding the Veteran's service and exposure history, including clarification of his periods of service after October 2000 and verification of any exposure to contaminated ground water at Kelly Air Force Base during active duty.

The Board denied service connection for prostate cancer residuals, finding that the Veteran's prostate cancer did not have its onset during service and is not related to exposure to toxic chemicals in service.

The Board has denied service connection for ischemic heart disease, prostate cancer, and chronic obstructive pulmonary disease. The claim of service connection for myasthenia gravis as secondary to herbicide exposure is remanded.

The Board denied a compensable disability rating for the Veteran's service-connected erectile dysfunction associated with prostate cancer, finding that there is no evidence of penile deformity. The Veteran does not receive a schedular rating but receives special monthly compensation benefits due to loss of use of a creative organ.

The Veteran's prostate cancer and diabetes mellitus, type II are granted as due to herbicide agent exposure during his nautical service.

The Veteran's prostate cancer, coronary artery disease, and hypertension are presumed to have been incurred during his active service in Okinawa due to exposure to herbicide agents. Service connection for erectile dysfunction is granted as secondary to the service-connected prostate cancer.,Service connection for acid reflux disease and asthma is remanded for further development.